AIMS/HYPOTHESIS: Patients with type 1 diabetes mellitus are more susceptible than healthy individuals to exercise-induced oxidative stress and vascular endothelial dysfunction, which has important implications for the progression of disease. Thus, in the present study, we designed a randomised double-blind, placebo-controlled trial to test the original hypothesis that oral prophylaxis with vitamin C attenuates rest and exercise-induced free radical-mediated lipid peroxidation in type 1 diabetes mellitus. METHODS: All data were collected from hospitalised diabetic patients. The electron paramagnetic resonance spectroscopic detection of spin-trapped alpha-phenyl-tert-butylnitrone (PBN) adducts was combined with the use of supporting markers of lipid peroxidation and non-enzymatic antioxidants to assess exercise-induced oxidative stress in male patients with type 1 diabetes (HbA(1c) 7.9 +/- 1%, n = 12) and healthy controls (HbA(1c) 4.6 +/- 0.5%, n = 14). Following participant randomisation using numbers in a sealed envelope, venous blood samples were obtained at rest, after a maximal exercise challenge and before and 2 h after oral ingestion of 1 g ascorbate or placebo. Participants and lead investigators were blinded to the administration of either placebo or ascorbate treatments. Primary outcome was the difference in changes in free radicals following ascorbate ingestion. RESULTS:Six diabetic patients and seven healthy control participants were randomised to each of the placebo and ascorbate groups. Diabetic patients (n = 12) exhibited an elevated concentration of PBN adducts (p < 0.05 vs healthy, n = 14), which were confirmed as secondary, lipid-derived oxygen-centred alkoxyl (RO.) radicals (a(nitrogen) = 1.37 mT and abeta(hydrogen) = 0.18 mT). Lipid hydroperoxides were also selectively elevated and associated with a depression of retinol and lycopene (p < 0.05 vs healthy). Vitamin C supplementation increased plasma vitamin C concentration to a similar degree in both groups (p < 0.05 vs pre-supplementation) and attenuated the exercise-induced oxidative stress response (p < 0.05 vs healthy). There were no selective treatment differences between groups in the primary outcome variable. CONCLUSIONS/ INTERPRETATION: These findings are the first to suggest that oral vitamin C supplementation provides an effective prophylaxis against exercise-induced free radical-mediated lipid peroxidation in human diabetic blood. CLINICAL TRIALS REGISTRATION NUMBER: ISRCTN96164937.
RCT Entities:
AIMS/HYPOTHESIS: Patients with type 1 diabetes mellitus are more susceptible than healthy individuals to exercise-induced oxidative stress and vascular endothelial dysfunction, which has important implications for the progression of disease. Thus, in the present study, we designed a randomised double-blind, placebo-controlled trial to test the original hypothesis that oral prophylaxis with vitamin C attenuates rest and exercise-induced free radical-mediated lipid peroxidation in type 1 diabetes mellitus. METHODS: All data were collected from hospitalised diabeticpatients. The electron paramagnetic resonance spectroscopic detection of spin-trapped alpha-phenyl-tert-butylnitrone (PBN) adducts was combined with the use of supporting markers of lipid peroxidation and non-enzymatic antioxidants to assess exercise-induced oxidative stress in male patients with type 1 diabetes (HbA(1c) 7.9 +/- 1%, n = 12) and healthy controls (HbA(1c) 4.6 +/- 0.5%, n = 14). Following participant randomisation using numbers in a sealed envelope, venous blood samples were obtained at rest, after a maximal exercise challenge and before and 2 h after oral ingestion of 1 g ascorbate or placebo. Participants and lead investigators were blinded to the administration of either placebo or ascorbate treatments. Primary outcome was the difference in changes in free radicals following ascorbate ingestion. RESULTS: Six diabeticpatients and seven healthy control participants were randomised to each of the placebo and ascorbate groups. Diabeticpatients (n = 12) exhibited an elevated concentration of PBN adducts (p < 0.05 vs healthy, n = 14), which were confirmed as secondary, lipid-derived oxygen-centred alkoxyl (RO.) radicals (a(nitrogen) = 1.37 mT and abeta(hydrogen) = 0.18 mT). Lipid hydroperoxides were also selectively elevated and associated with a depression of retinol and lycopene (p < 0.05 vs healthy). Vitamin C supplementation increased plasma vitamin C concentration to a similar degree in both groups (p < 0.05 vs pre-supplementation) and attenuated the exercise-induced oxidative stress response (p < 0.05 vs healthy). There were no selective treatment differences between groups in the primary outcome variable. CONCLUSIONS/ INTERPRETATION: These findings are the first to suggest that oral vitamin C supplementation provides an effective prophylaxis against exercise-induced free radical-mediated lipid peroxidation in humandiabetic blood. CLINICAL TRIALS REGISTRATION NUMBER: ISRCTN96164937.
Authors: T M Berger; M C Polidori; A Dabbagh; P J Evans; B Halliwell; J D Morrow; L J Roberts; B Frei Journal: J Biol Chem Date: 1997-06-20 Impact factor: 5.157
Authors: R A Anderson; M L Evans; G R Ellis; J Graham; K Morris; S K Jackson; M J Lewis; A Rees; M P Frenneaux Journal: Atherosclerosis Date: 2001-02-01 Impact factor: 5.162
Authors: D Thompson; C Williams; M Kingsley; C W Nicholas; H K Lakomy; F McArdle; M J Jackson Journal: Int J Sports Med Date: 2001-01 Impact factor: 3.118
Authors: Gareth W Davison; Lindsay George; Simon K Jackson; Ian S Young; Bruce Davies; Damian M Bailey; John R Peters; Tony Ashton Journal: Free Radic Biol Med Date: 2002-12-01 Impact factor: 7.376
Authors: Gareth W Davison; Tony Ashton; Jane McEneny; Ian S Young; Bruce Davies; Damian M Bailey Journal: J Physiol Biochem Date: 2012-09 Impact factor: 4.158
Authors: Ryan Janjuha; Diane Bunn; Richard Hayhoe; Lee Hooper; Asmaa Abdelhamid; Shaan Mahmood; Joseph Hayden-Case; Will Appleyard; Sophie Morris; Ailsa Welch Journal: Nutrients Date: 2020-05-18 Impact factor: 5.717
Authors: Markus Mattila; Iris Erlund; Hye-Seung Lee; Sari Niinistö; Ulla Uusitalo; Carin Andrén Aronsson; Sandra Hummel; Hemang Parikh; Stephen S Rich; William Hagopian; Jorma Toppari; Åke Lernmark; Anette G Ziegler; Marian Rewers; Jeffrey P Krischer; Jill M Norris; Suvi M Virtanen Journal: Diabetologia Date: 2019-11-14 Impact factor: 10.122